J 2019

Endoscopic or Surgical Myotomy in Patients with Idiopathic Achalasia

WERNER, Y. B., B. HAKANSON, J. MARTINEK, A. REPICI, Rahden BHA. VON et. al.

Základní údaje

Originální název

Endoscopic or Surgical Myotomy in Patients with Idiopathic Achalasia

Autoři

WERNER, Y. B., B. HAKANSON, J. MARTINEK, A. REPICI, Rahden BHA. VON, A. J. BREDENOORD, R. BISSCHOPS, H. MESSMANN, M. C. VOLLBERG, T. NODER, J. F. KERSTEN, O. MANN, J. IZBICKI, A. PAZDRO, U. FUMAGALLI, R. ROSATI, C. T. GERMER, M. P. SCHIJVEN, A. EMMERMANN, Renteln D. VON, P. FOCKENS, G. BOECKXSTAENS a T. ROSCH

Vydání

New England Journal of Medicine, Waltham, Massachussetts Medical Society, 2019, 0028-4793

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30230 Other clinical medicine subjects

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 74.699

UT WoS

000505219800007

Klíčová slova česky

PNEUMATIC DILATIONADVERSE EVENTSHELLER MYOTOMYPOEMOUTCOMESRISK

Klíčová slova anglicky

PNEUMATIC DILATIONADVERSE EVENTSHELLER MYOTOMYPOEMOUTCOMESRISK

Štítky

Příznaky

Mezinárodní význam
Změněno: 7. 12. 2021 13:47, Bc. Hana Vladíková, BBA

Anotace

V originále

BACKGROUND Pneumatic dilation and laparoscopic Heller's myotomy (LHM) are established treatments for idiopathic achalasia. Peroral endoscopic myotomy (POEM) is a less invasive therapy with promising early study results. METHODS In a multicenter, randomized trial, we compared POEM with LHM plus Dor's fundoplication in patients with symptomatic achalasia. The primary end point was clinical success, defined as an Eckardt symptom score of 3 or less (range, 0 to 12, with higher scores indicating more severe symptoms of achalasia) without the use of additional treatments, at the 2-year follow-up; a noninferiority margin of -12.5 percentage points was used in the primary analysis. Secondary end points included adverse events, esophageal function, Gastrointestinal Quality of Life Index score (range, 0 to 144, with higher scores indicating better function), and gastroesophageal reflux. RESULTS A total of 221 patients were randomly assigned to undergo either POEM (112 patients) or LHM plus Dor's fundoplication (109 patients). Clinical success at the 2-year follow-up was observed in 83.0% of patients in the POEM group and 81.7% of patients in the LHM group (difference, 1.4 percentage points; 95% confidence interval [CI], -8.7 to 11.4; P = 0.007 for noninferiority). Serious adverse events occurred in 2.7% of patients in the POEM group and 7.3% of patients in the LHM group. Improvement in esophageal function from baseline to 24 months, as assessed by measurement of the integrated relaxation pressure of the lower esophageal sphincter, did not differ significantly between the treatment groups (difference, -0.75 mm Hg; 95% CI, -2.26 to 0.76), nor did improvement in the score on the Gastrointestinal Quality of Life Index (difference, 0.14 points; 95% CI, -4.01 to 4.28). At 3 months, 57% of patients in the POEM group and 20% of patients in the LHM group had reflux esophagitis, as assessed by endoscopy; at 24 months, the corresponding percentages were 44% and 29%. CONCLUSIONS In this randomized trial, POEM was noninferior to LHM plus Dor's fundoplication in controlling symptoms of achalasia at 2 years. Gastroesophageal reflux was more common among patients who underwent POEM than among those who underwent LHM.

Návaznosti

90090, velká výzkumná infrastruktura
Název: CZECRIN II